S

Scribe Therapeutics

124 employees

Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

S

Scribe Therapeutics raised undisclosed on June 16, 2023

Investors: Prevail Therapeutics

FAQ